galactosamine has been researched along with Leukemia P388 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borg, AL; Skog, S; Stenberg, K; Tribukait, B | 1 |
| Green, D; Hammer, CF; McPherson, E; Schein, PS; Talebian, A | 1 |
| Dean, SW; Green, D; McPherson, E; Schein, PS | 1 |
3 other study(ies) available for galactosamine and Leukemia P388
| Article | Year |
|---|---|
Comparative studies of galactose-6-mustard and L-phenylalanine mustard on cell growth and cell cycle kinetics in vitro.
Topics: Alkylating Agents; Animals; Cell Cycle; Cell Division; CHO Cells; Cricetinae; DNA, Neoplasm; Fibroblasts; Galactosamine; Leukemia P388; Melphalan; Mice; Thymidine; Tritium; Tumor Cells, Cultured | 1992 |
6-bis-(2-chloroethyl)amino-6-deoxy-D-galactopyranose hydrochloride: synthesis, chemical characterization, murine P388 antitumor activity, and bone marrow toxicity.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Bone Marrow; Galactosamine; Humans; Leukemia P388; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA | 1989 |
6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
Topics: Animals; Bone Marrow; DNA Replication; Drug Evaluation, Preclinical; Female; Galactosamine; Hematopoietic Stem Cells; Leukemia P388; Leukemia, Experimental; Leukopenia; Male; Mechlorethamine; Melphalan; Mice; Mice, Inbred DBA; Neutrophils; Structure-Activity Relationship | 1987 |